Mass spectrometry-based urinary metabolomics for the investigation on the mechanism of action of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves against ischemic stroke in rats
- PMID: 31125596
- DOI: 10.1016/j.jep.2019.111969
Mass spectrometry-based urinary metabolomics for the investigation on the mechanism of action of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves against ischemic stroke in rats
Abstract
Ethnopharmacological relevance: As a traditional Chinese medicine, Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves (ESL) can treat ischemic, neurasthenia, and hypertension diseases. However, only few studies have been conducted on the mechanism of action of ESL for ischemic disease treatment.
Aim of the study: This study aimed to discover the potential biomarkers in the rats caused by ischemic stroke and build a gene-enzyme-biomarker network to explore the mechanism of ESL treatment on ischemic stroke further.
Materials and methods: The urinary metabolomics strategy was developed by combining UPLC-Q-TOF/MS with multivariate data analysis. The gene-enzyme-biomarker network was built by Cytoscape 3.6.0 on the basis of the potential biomarkers filtered out via urinary metabolomic analysis. Then, the potential target enzymes of ESL in the treatment of ischemic stroke were selected for further validation analysis via the ELISA kits.
Results: A total of 42 biomarkers associated with ischemic stroke have been identified, among which 38 species can be adjusted by ESL, including 5'-methylthioadenosine, prostaglandin A2, l-methionine, aldosterone, 11b-hydroxyprogesterone, prostaglandin E3, dehydroepiandrosterone, taurine, 5-methoxyindoleacetate, and p-cresol glucuronide. These biomarkers were involved in several metabolic pathways, including taurine and hypotaurine, arachidonic acid, cysteine and methionine, steroid hormone biosynthesis, tryptophan, and tyrosine metabolism pathways. The gene-enzyme-biomarker network was built, and three predicted target proteins, including cyclooxygenase-2 (COX-2), monoamine oxidase (MAO), and nitric oxide synthase (NOS), were selected as the potential target enzymes for ESL in ischemic stroke treatment.
Conclusions: All results showed that ESL can play a therapeutic role in treating ischemic stroke through different pathways. This study will provide an overall view of the mechanism underlying the action of ESL against ischemic stroke.
Keywords: Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves; Ischemic stroke; Metabolomics; UPLC-Q-TOF/MS.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Mass spectrometry-based serum lipidomics strategy to explore the mechanism of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves in the treatment of ischemic stroke.Food Funct. 2021 May 21;12(10):4519-4534. doi: 10.1039/d0fo02845b. Epub 2021 Apr 23. Food Funct. 2021. PMID: 33890948
-
Therapeutic effect of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves on ischemic stroke via the microbiota-gut-brain axis.Phytother Res. 2023 Oct;37(10):4801-4818. doi: 10.1002/ptr.7947. Epub 2023 Jul 30. Phytother Res. 2023. PMID: 37518502
-
Effects of Acanthopanax senticosus (Rupr. & Maxim.) Harms on cerebral ischemia-reperfusion injury revealed by metabolomics and transcriptomics.J Ethnopharmacol. 2021 Jan 10;264:113212. doi: 10.1016/j.jep.2020.113212. Epub 2020 Aug 5. J Ethnopharmacol. 2021. PMID: 32768643
-
Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look.J Ethnopharmacol. 2000 Oct;72(3):345-93. doi: 10.1016/s0378-8741(00)00181-1. J Ethnopharmacol. 2000. PMID: 10996277 Review.
-
Findings of Russian literature on the clinical application of Eleutherococcus senticosus (Rupr. & Maxim.): A narrative review.J Ethnopharmacol. 2021 Oct 5;278:114274. doi: 10.1016/j.jep.2021.114274. Epub 2021 Jun 2. J Ethnopharmacol. 2021. PMID: 34087398 Review.
Cited by
-
Gut microbiota and metabolic profiles in chronic intermittent hypoxia-induced rats: disease-associated dysbiosis and metabolic disturbances.Front Endocrinol (Lausanne). 2024 Jan 12;14:1224396. doi: 10.3389/fendo.2023.1224396. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38283743 Free PMC article.
-
Metabolomics analysis of serum and urine in type 1 diabetes patients with different time in range derived from continuous glucose monitoring.Diabetol Metab Syndr. 2024 Jan 19;16(1):21. doi: 10.1186/s13098-024-01257-4. Diabetol Metab Syndr. 2024. PMID: 38238828 Free PMC article.
-
Eleutherococcus senticosus (Acanthopanax senticosus): An Important Adaptogenic Plant.Molecules. 2025 Jun 8;30(12):2512. doi: 10.3390/molecules30122512. Molecules. 2025. PMID: 40572479 Free PMC article. Review.
-
Dietary supplementation of Acanthopanax senticosus extract alleviates motor deficits in MPTP-induced Parkinson's disease mice and its underlying mechanism.Front Nutr. 2023 Feb 14;9:1121789. doi: 10.3389/fnut.2023.1121789. eCollection 2023. Front Nutr. 2023. PMID: 36865944 Free PMC article.
-
An Integrated Metabolomic Screening Platform Discovers the Potential Biomarkers of Ischemic Stroke and Reveals the Protective Effect and Mechanism of Folic Acid.Front Mol Biosci. 2022 May 18;9:783793. doi: 10.3389/fmolb.2022.783793. eCollection 2022. Front Mol Biosci. 2022. PMID: 35664672 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials